Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Cymabay Therapeutics Inc. (CBAY)

« Back to company index

CBAY Chatter Timeline

Stock Ticker for CBAY

Most Active Tweeters for CBAY

UserTweets
@macondailynews 1
@OlympiaReport 1
@AmericanBanking 1
@realmoney 1
@stocknewstimes 1

Recent Tweets for CBAY

dailypoliticaln @dailypoliticaln
Zacks: Brokerages Anticipate CymaBay Therapeutics Inc $CBAY Will Post Earnings of -$0.37 Per Share https://t.co/b9LIcuJrIx
2:09pm
HowieChamberla1 @HowieChamberla1
RT @realmoney: Investors in CymaBay Therapeutics $CBAY need patience and discipline - @BruceKamich https://t.co/23im3vbDJU
12:09pm
realmoney @realmoney
Investors in CymaBay Therapeutics $CBAY need patience and discipline - @BruceKamich https://t.co/23im3vbDJU
12:09pm
OlympiaReport @OlympiaReport
-$0.37 EPS Expected for CymaBay Therapeutics Inc $CBAY This Quarter https://t.co/TcF38vJK72
September 12th 2019, 12:09pm
WeekHerald @WeekHerald
Zacks: Brokerages Expect CymaBay Therapeutics Inc $CBAY to Post -$0.37 EPS https://t.co/0uVolFLa1a
September 12th 2019, 12:09pm
TickerReport @TickerReport
-$0.37 EPS Expected for CymaBay Therapeutics Inc $CBAY This Quarter https://t.co/NIXgmCGoXo
September 12th 2019, 11:09am
TradeFlags @TradeFlags
TD SELL $CBAY at 6.34, Supp 5.50 Resis 6.34 R15 HiLo 17% T1Y 16 buy 1.6 fwdPE -3.8 DIV N/A #CymaBay Th #stocks… https://t.co/iDESKAhktl
September 11th 2019, 12:09am
TheMarketsDaily @TheMarketsDaily
Analysts Anticipate CymaBay Therapeutics Inc $CBAY to Post -$0.37 Earnings Per Share https://t.co/iZxwQZtNMq
September 9th 2019, 2:09pm
stocknewstimes @stocknewstimes
Zacks: Analysts Expect CymaBay Therapeutics Inc $CBAY to Announce -$0.37 EPS https://t.co/lJ77lAVh3k
September 9th 2019, 2:09pm
AmericanBanking @AmericanBanking
Zacks: Analysts Expect CymaBay Therapeutics Inc $CBAY to Announce -$0.37 EPS https://t.co/x1QcAgqvgk #stocks
September 9th 2019, 2:09pm
macondailynews @macondailynews
Zacks: Analysts Expect CymaBay Therapeutics Inc $CBAY to Announce -$0.37 EPS https://t.co/jhMELZra6w
September 9th 2019, 2:09pm
dispatchtribune @dispatchtribune
CymaBay Therapeutics Inc $CBAY Given Average Rating of “Buy” by Analysts https://t.co/YCkeRFYtbh
September 8th 2019, 6:09pm
AmericanBanking @AmericanBanking
CymaBay Therapeutics Inc $CBAY Receives Average Recommendation of “Buy” from Brokerages https://t.co/QIr0vT9qc3 #stocks
August 9th 2019, 2:08am
ZolmaxNews @ZolmaxNews
CymaBay Therapeutics $CBAY Shares Up 6.5% After Earnings Beat https://t.co/KEnmUFlBGm
August 8th 2019, 6:08pm
LargeVoidBot @LargeVoidBot
Daily Reversal (11:35): $CBAY Last: 5.77; pHigh: 5.73; rVol: 2.049; pClose: 5.56; LOD: 5.3300; Perf: 3.8%
August 8th 2019, 11:08am
SiteFocusHQ @SiteFocusHQ
$CBAY Qualitative Analysis of recent earnings identified CymaBay Therapeutics, Inc (NASDAQ: CBAY ) business focus o… https://t.co/WeM6Pn7Krk
August 7th 2019, 11:08pm
SeekingAlpha @SeekingAlpha
$CBAY - Cymabay Therapeutics, Inc. (CBAY) CEO Sujal Shah on Q2 2019 Results - Earnings Call Transcript https://t.co/YFqt7s7tAO
August 7th 2019, 11:08pm
MarketCurrents @MarketCurrents
$CBAY - CymaBay Therapeutics EPS beats by $0.02 https://t.co/tS96RYQzpG
August 7th 2019, 4:08pm
confcalltran @confcalltran
CymaBay Therapeutics Just Filed Its Quarterly Report: Net Loss Per Common ... https://t.co/iP3mgquq82 $CBAY
August 7th 2019, 4:08pm
TheMarketsDaily @TheMarketsDaily
CymaBay Therapeutics $CBAY to Release Earnings on Wednesday https://t.co/7jpcoW1Mto
August 6th 2019, 6:08pm
stocknewstimes @stocknewstimes
CymaBay Therapeutics $CBAY to Release Earnings on Wednesday https://t.co/wPVu1TKfnj
August 6th 2019, 6:08pm
TranscriptDaily @TranscriptDaily
CymaBay Therapeutics $CBAY to Release Earnings on Wednesday https://t.co/D7SYcW4MKe
August 6th 2019, 6:08pm
dakotafinancial @dakotafinancial
CymaBay Therapeutics $CBAY Shares Down 6.9% https://t.co/uXFPvXRyxZ
August 6th 2019, 12:08am
InsiderAlertsIA @InsiderAlertsIA
$CBAY: New Insider Filing on Chief Commercial Officer JANET DORLING: https://t.co/AdnrXiSbbQ
August 5th 2019, 7:08pm
StockTexts @StockTexts
$CBAY CymaBay Therapeutics Inc. SEC Filing: Form 4 https://t.co/2d8633aHqA
August 5th 2019, 7:08pm
StockTexts @StockTexts
$CBAY CymaBay Therapeutics Inc. SEC Filing: Form 3 https://t.co/f2A0oGs06T
August 5th 2019, 7:08pm
confcalltran @confcalltran
CymaBay Therapeutics's Chief Commercial Officer was just granted 341,000 options https://t.co/Umd0um6RfW $CBAY
August 5th 2019, 7:08pm
confcalltran @confcalltran
CymaBay Therapeutics's Chief Commercial Officer just declared ownership of no shares of CymaBay https://t.co/7XW9bmaL3q $CBAY
August 5th 2019, 6:08pm
MaisaCorp @MaisaCorp
$CBAY Appoints Janet Dorling as Chief Comml Officer
August 5th 2019, 5:08pm
ZolmaxNews @ZolmaxNews
CymaBay Therapeutics $CBAY Set to Announce Earnings on Wednesday https://t.co/f4Xw5EGxfX
August 5th 2019, 3:08pm
biotechw2019 @biotechw2019
$CBAY new 52 week closing low coming
August 5th 2019, 1:08pm
MyronsUber @MyronsUber
Is to time to buy $CBay
August 5th 2019, 11:08am
dailypoliticaln @dailypoliticaln
CymaBay Therapeutics $CBAY Upgraded at ValuEngine https://t.co/zKlNfwlsNz
August 5th 2019, 9:08am
dakotafinancial @dakotafinancial
CymaBay Therapeutics $CBAY Upgraded at ValuEngine https://t.co/cv2E7jLCMR
August 5th 2019, 9:08am
ConsumerFeed @ConsumerFeed
CymaBay Therapeutics $CBAY Lifted to “Strong-Buy” at ValuEngine https://t.co/EoHhDDNDdr
August 4th 2019, 8:08pm
registrarjourn @registrarjourn
CymaBay Therapeutics $CBAY Rating Increased to Strong-Buy at ValuEngine https://t.co/hc2RUJLHaR
August 3rd 2019, 8:08pm
EnterpriseLeade @EnterpriseLeade
CymaBay Therapeutics $CBAY Rating Increased to Strong-Buy at ValuEngine https://t.co/Ds8453bDjL
August 3rd 2019, 8:08pm
TranscriptDaily @TranscriptDaily
CymaBay Therapeutics $CBAY Rating Increased to Strong-Buy at ValuEngine https://t.co/FJlN2hXCx0
August 3rd 2019, 8:08pm
ZolmaxNews @ZolmaxNews
CymaBay Therapeutics $CBAY Upgraded by ValuEngine to “Strong-Buy” https://t.co/kNTsSZ5vVC
August 3rd 2019, 4:08pm
TickerReport @TickerReport
CymaBay Therapeutics $CBAY Stock Rating Lowered by BidaskClub https://t.co/oBiEyWgNcp
August 3rd 2019, 12:08pm
TheMarketsDaily @TheMarketsDaily
CymaBay Therapeutics $CBAY Stock Rating Lowered by BidaskClub https://t.co/klKXulL3FC
August 3rd 2019, 12:08pm
macondailynews @macondailynews
CymaBay Therapeutics $CBAY Stock Rating Lowered by BidaskClub https://t.co/PF2ujinnPx
August 3rd 2019, 12:08pm
BlueBioNow @BlueBioNow
$CBAY Lets see how this turns out -2.77 % https://t.co/5FMbJjXg5G
August 3rd 2019, 6:08am
registrarjourn @registrarjourn
Analysts Expect CymaBay Therapeutics Inc $CBAY to Announce -$0.37 Earnings Per Share https://t.co/OzFlMcyX2k
August 3rd 2019, 12:08am
EnterpriseLeade @EnterpriseLeade
Analysts Expect CymaBay Therapeutics Inc $CBAY to Announce -$0.37 Earnings Per Share https://t.co/PSApGrIh9f
August 3rd 2019, 12:08am
TranscriptDaily @TranscriptDaily
Analysts Expect CymaBay Therapeutics Inc $CBAY to Announce -$0.37 Earnings Per Share https://t.co/okYWnyIdDY
August 3rd 2019, 12:08am
TranscriptDaily @TranscriptDaily
CymaBay Therapeutics $CBAY Downgraded by BidaskClub https://t.co/bgnwHRHOmj
August 2nd 2019, 2:08pm
registrarjourn @registrarjourn
CymaBay Therapeutics $CBAY Downgraded by BidaskClub https://t.co/KIVtkNrpx7
August 2nd 2019, 2:08pm
EnterpriseLeade @EnterpriseLeade
CymaBay Therapeutics $CBAY Downgraded by BidaskClub https://t.co/f5HixLj9PV
August 2nd 2019, 2:08pm
macondailynews @macondailynews
CymaBay Therapeutics $CBAY Scheduled to Post Earnings on Wednesday https://t.co/zNDVAwzBqi
August 2nd 2019, 10:08am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.